cbdMD, INC.

YCBD

CIK 0001644903 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$5M
↓-1.9% -$97Kvs FY2024 (Q4)
Operating Income
$3M
↓-10.5% -$347Kvs FY2024 (Q4)
Gross Profit
$3M
↓-11.7% -$399Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
65/100
  • Profitability
    0ROIC -37.2% (10% = solid, 20%+ = moat)
  • Liquidity
    78Current Ratio 2.05 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 1.83x (1.0+ = capital-efficient)
  • Growth
    10Revenue YoY -1.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -5.7% · trend +3.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$185K
investment in PP&E
Dividends paid (TTM)
$1M
cash returned to holders
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$12M
everything owned
Total liabilities
$3M
everything owed
Stockholders' equity
$9M
shareholder claim
Net debt
$-3M
Net cash position ($3M)

Recent performance · 38 quarters

Revenue↓-1.9% -$97K
$5M
Net Income↓-1975.7% -$298K
$-283K
Free Cash Flow↓-102.6% -$495K
$-977K
Operating Margin↓-4.0pts
-5.7%

Drill down